Skip to main content
BBNXBeta Bionics, Inc.Sell5.7·$16.18-4.82%
BBNX · Why this verdict

Why Beta Bionics (BBNX) is rated SELL

Updated

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

VerdictSELL
Overall score5.7/10
ConfidenceMEDIUM
MacroNEUTRAL

Thesis pillars

Business quality screens below the engine's floor at 2.5 versus a 4.0 minimum, with value-trap signals flagging margin compression (operating margin of -50.8%) and material insider selling (6 sells, 0.21% of cap).

Stable
Warnings
Expectation
The quality score climbs back above the 4.0 floor and the value-trap signal count drops from its current level.

CounterThe perfect 4-quarter earnings beat streak suggests operational execution remains strong even as quality metrics screen weak.

Revenue growth is strong at 57% year over year, and the peer-ranking data calls the company an industry growth leader.

Stable
Growth breakdown
Expectation
Revenue growth stays near or above the current 57% pace over the next several quarters.

CounterThe business is cash-burning, with free cash flow at -40% of revenue, meaning rapid growth is coming at a meaningful cash cost.

The company has beaten earnings estimates in all of the last 4 quarters with an average surprise of 32.9%, and the engine flags an earnings catalyst in 25 days backed by that perfect beat streak.

Stable
Earnings
Expectation
The beat streak continues into the upcoming report in 25 days.

CounterQuality screens below the engine's floor at 2.5 versus a 4.0 minimum, with value-trap signals flagging margin compression and material insider selling, which could mean the beats aren't translating into durable profitability.

The setup is characterized as a recovery - a death cross with MACD improving and RSI at 63 - with momentum at 5.9 clearing the 5.0 recovery threshold, even though price remains below the 200-day moving average in a confirmed downtrend (the moving average sloping down 3.8% over 30 days).

Stable
Momentum breakdown
Expectation
Price reclaims the 200-day moving average and the confirmed downtrend clears.

CounterThe asymmetry gate still failed at -0.03, essentially flat, meaning the momentum recovery hasn't yet produced a favorable risk/reward setup.

Insiders have sold $596,204 (0.080% of market cap) over the past 90 days across 12 sell transactions, and the price target is already described as reached (-0.4% versus the original target).

Stable
Insider
Expectation
Insider selling activity slows and a new catalyst lifts the take-profit target meaningfully above the current price.

CounterThe engine still classifies this insider selling severity as only minor, a much lower concern level than the extreme selling flagged at other names, suggesting it may not signal a meaningful loss of confidence.

TrendMatrix Research · core thesis

Engine thesis — one sentence

Beta Bionics shows industry-leading revenue growth and a perfect four-quarter earnings beat streak heading into a catalyst in 25 days, but quality metrics below the engine's floor, ongoing cash burn, and a price target already reached keep the risk/reward setup only marginally positive.

Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.

Per-dimension breakdown

Value

5.3/10data confidence 33%
ComponentSub-score
P/S5.7
Analyst target5.0

Quality

2.9/10data confidence 100%
ComponentSub-score
ROE0.0
ROA0.0
Gross margin7.4
Op margin0.0
Net margin0.0
Current ratio5.0
FCF quality0.0
Moat7.2
Piotroski F6.7
  • Cash-burning: FCF -40% of revenue
  • Quality concerns

Growth

10.0/10data confidence 33%
ComponentSub-score
Rev growth10.0
  • Strong growth: 57% YoY

Momentum

4.2/10data confidence 100%
ComponentSub-score
RSI3.7
MACD7.3
OBV1.0
MA position6.0
Volume3.0
  • Volume distribution (falling OBV)
  • Below 200-MA, MA slope -4.0%/30d — confirmed downtrend

Sentiment

6.6/10data confidence 100%
ComponentSub-score
Analyst rating7.0
Price target7.5
erm sentiment5.0

Insider

5.5/10data confidence 75%
ComponentSub-score
materiality4.5
insider conviction2.0
holder change10.0
  • Modest insider selling — $596,204 (0.080% of mkt cap)
  • Institutions accumulating

Peer rank

5.5/10data confidence 80%
ComponentSub-score
value rank2.1
quality rank1.4
growth rank9.4
  • Industry growth leader
  • Conservative debt levels

Technical

3.0/10data confidence 100%
ComponentSub-score
bollinger3.1
support resistance3.1
52w position0.0
gap6.0

Risk (lower is worse)

5.3/10data confidence 100%
ComponentSub-score
short interest4.7
days to cover5.4
volatility0.0
put call10.0
implied vol0.0
max pain risk7.0
debt equity9.9
  • High IV: 112%
  • Concentration risks: 2 HIGH, 1 MED (10-K Item 1A — sized via position_sizing, validated via buy_confidence)

Catalyst

7.5/10data confidence 100%
ComponentSub-score
erm5.0
earnings history10.0
earnings timing5.0
surprise avg10.0
  • Perfect beat streak: 4Q

How the verdict was assembled

Engine trigger

Quality below minimum threshold.

Engine technical detail
verdict_path: L1:HARD_BLOCK
Passed (6)
  • INSIDER:OK
  • 8K:CLEAN
  • NEWS_EVENTS:NONE_RECENT
  • EARNINGS_PROXIMITY:22d clear
  • SEMI_CYCLE_PEAK:CLEAR
  • MATERIALS_CYCLE_PEAK:CLEAR
Failed (3)
  • MOMENTUM:4.2<4.5
  • ASYMMETRY:0.2<1.5@spot
  • DEATH_CROSS:HARD_BLOCK
Warning (0)

none

Reward-to-Risk
0.21
Upside
+3.1%
Downside
15.0%
Sizing output
AVOID

SetupRecovery Death cross but MACD improving, RSI 63

EdgeCatalyst-Driven Earnings in 22d with 4/4 beat streak

SuitabilitySpeculative Drawdown -50% (>40% off 52w high)

Investment implication

The L1 gate blocked the positive-verdict path: a hard-floor threshold was breached, so dimensional pillars — including Growth at 10.0 could not lift the engine output above the verdict floor. Failed gate signal: MOMENTUM:4.2<4.5.

The strongest dimensions are Growth at 10.0, Catalyst at 7.5, and Sentiment at 6.6; the weakest are Quality at 2.9, Technical at 3.0, and Momentum at 4.2. The V9 engine flagged 3 failed gates, producing an asymmetric reward-to-risk of 0.21 and an engine sizing output of AVOID.

What would invalidate the thesis

Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.

  • P1Strong Growth Industry Leader

    Trip ifRevenue growth falls below 20% year over year, down from the current 57% pace.

  • P2Perfect Earnings Beat Streak

    Trip ifAverage earnings surprise falls below 0% for 2 consecutive quarters.

  • P3Momentum Recovering Confirmed Downtrend

    Trip ifPrice rises more than 5% above the 200-day moving average, reversing the current confirmed downtrend.

  • P4Quality Below Floor Value Trap

    Trip ifThe quality score rises above 4.0, clearing the engine's floor from the current 2.5.

  • P5Insider Selling Target Reached

    Trip ifThe asymmetry ratio rises above 1.0 from the current -0.03.

Engine reasoning is mechanically derived from pipeline gate outputs. See decision view.

Home Stocks BBNX Why this verdict